A. Signore et al., IN-VIVO MEASUREMENT OF IMMUNOGLOBULIN ACCUMULATION IN THE PANCREAS OFRECENT-ONSET TYPE-1 DIABETIC-PATIENTS, Clinical and experimental rheumatology, 14, 1996, pp. 41-45
Objective. The possibility to quantify in vivo the severity of the inf
lammatory process in the pancreas of patients with recent onset insuli
n dependent diabetes mellitus (IDDM) could be of great relevance for f
ollow-up studies involving immunotherapy. Scintigraphy with radiolabel
led human polyclonal immunoglobulins (Tc-99m-HIG) is currently used fo
r the diagnosis and follow-up of several acute and chronic inflammator
y diseases. In this longitudinal study we have investigated To what ex
tent Tc-99m-HIG accumulate in the pancreas of patients with recent ons
et IDDM and in subjects at risk to develop IDDM. Methods. Combined com
puterised tomography and gamma camera imaging were used so measure the
radioactivity in the pancreatic region, as the pancreas/bone radioact
ivity ratio (P/B). Patients with IDDM (n=15) were investigated at the
time of diagnosis and after 1 year. Five pre-diabetic ICA+ve subjects
and 8 age and sex matched normal subjects were also investigated. Resu
lts. Eight out of 15 newly diagnosed IDDM patients and 2/5 ICA+ve subj
ects showed a significant accumulation of radiolabelled HIG in the pan
creas (P/B higher than the upper 1st centile of normal subjects). One
year after the diagnosis a significant accumulation of immunoglobulins
was still detectable in the pancreas of IDDM patients positive who we
re positive at diagnosis. Conclusions. These results suggest that immu
noglobulins home and bind to the pancreas of patients with recent onse
t IDDM and also in some ICA+ve individuals. This may reflect an increa
sed vascular permeability of pancreatic capillaries as a consequence o
f the inflammatory process involving the islets. Thus, this technique
may be useful for monitoring the efficacy of immune intervention at di
agnosis.